View
11
Download
0
Category
Preview:
Citation preview
ARRO ContourAccelerated Partial Breast Irradiation
using HDR brachytherapy or EBRT
Michael Zhang (MSIV), Matthew Spraker, MD, PhD (PGY3)
Faculty Mentor: Janice Kim, MD
University of Washington / Seattle Cancer Care Alliance
Seattle, WA
November 16, 2015
CT Simulation and Prescription for Brachytherapy
• CT simulation
– Use at least 1.5mm slices to visualize catheters for dosimetry planning*.
– Scan from chin to bottom of diaphragms, including the entire ipsilateral breast and lung.
– Breath hold CT scan can be performed
• Dose is delivered as 3.4Gy BID x 5 days (34Gy total)
• 34 Gy prescribed to approximate 1cm radial distance from the device surface.
November 16, 2015
*We use 1.25mm slices at our institution
Simulation and Planning for Brachytherapy
• Targets and OARs
– CTV volume – device balloon/seroma cavity and clips if present.
– PTV eval – CTV volume plus 1cm radial expansion
– External Skin Surface contour– 3mm thickness for extent of balloon
– Trapped Air bubbles
– Whole breast
– Lungs, Ribs and Heart for left-sided lesions.
November 16, 2015
Targets and OARs for Brachytherapy
November 16, 2015
PTV Eval
Air bubble
CTV
Catheters
Rib
Skin surface
November 16, 2015
Targets and OARs for Brachytherapy
Simulation and Planning for EBRT
• CT scan from base of skull to bottom of diaphragms to ensure inclusion of entire lung, heart and breast
• Slice thickness of <5mm should be employed
• Field within field planning technique can be used to improve dosimetry, but IMRT planning was excluded from NSABP B39/RTOG 0413 protocol.
• Dose calculations with tissue inhomogeneity correction were required in the NSABP B39/RTOG 0413 protocol.
• Note treatment delivered in 3.85Gy BID x10 for total dose of 38.5Gy.
November 16, 2015
Simulation and Planning for EBRT
• Targets and OARs
– CTV – uniformly expand resection cavity 15mm
– PTV – uniformly expand CTV 10mm
– PTV_eval – excludes PTV within 5mm of skin or chest wall
– Skin
– Ipsilateral and contralateral breast
– Thyroid
– Ipsilateral and contralateral lungs
– Heart
November 16, 2015
Targets and OARs for EBRT
November 16, 2015
CTV
PTV_eval
Skin
Left lung
Right lung
Heart
Targets and OARs for EBRT
November 16, 2015
CTV
PTV_eval
Skin
Left lung
Right lung
Heart
Targets and OARs for EBRT
November 16, 2015
CTV
PTV_eval
Skin
Left lung
Right lung
Heart
Isodose lines for EBRT
November 16, 2015
Isodose lines for EBRT
November 16, 2015
Isodose lines for EBRT
November 16, 2015
APBI dose constraints (NSABP B39/RTOG 0413 )
Target or OAR Constraint
Target coverage PTV_Eval V90≥90%
Whole breast V150<50cc, V200<10cc, V50<60% whole breast
Volume (air+seroma)/PTV_Eval <10%
Skin Max dose<145%
Device to skin bridge distance ≥5mm (ideally ≥7mm)
Balloon/device symmetry Device ≤2mm from expected dimensions
Vol. trapped air limitation ([Vol trapped air/Vol PTV_EVAL] x 100%) ≤ %PTV_EVAL coverage – 90%
November 16, 2015
Single-entry intracavitary device
Vx = Volume receiving x% of prescription dose
APBI dose constraints (NSABP B39/RTOG 0413 )
Target or OAR Constraint
Target coverage PTV_Eval V90≥90%
Dose homogeneity V150≤V100/4
Whole breast V150<70ccV200<20ccV50<60% whole breast
Volume (air+seroma)/PTV_Eval <10%
Skin Max dose<100% prescription
Device to skin bridge distance ≥5mm (ideally ≥7mm)
Ribs Max dose<145% prescription
November 16, 2015
Multiple Independent Catheter Insertion
Vx = Volume receiving x% of prescription dose
APBI dose constraints (NSABP B39/RTOG 0413 )
Target or OAR Constraint
Target coverage PTV_Eval V90≥90%
Dose homogeneity Max dose ≤120% prescription dose
Ipsilateral breast V100<35% whole breastV50<60% whole breast
Contralateral breast Max dose at any point <3% prescribed dose
Ipsilateral lung V30<15% lung
Contralateral lung V5<15% lung
Heart V5<5% (R-sided lesions)V5<40% (L-sided lesions)
Thyroid Max dose at any point <3% prescribed dose
November 16, 2015
External beam radiotherapy
Recommended